Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes

Cytokine. 2000 Jun;12(6):774-9. doi: 10.1006/cyto.1999.0649.

Abstract

The soluble IL-6 receptor (sIL-6R) can increase IL-6-induced signalling by forming a complex with IL-6 and membrane-bound gp130 (the receptor beta chain which transduces signals). The conditions affecting this response to sIL-6R were studied using fibrinogen release from HepG2 hepatocytes. Exogenous sIL-6R had no effect alone or in the presence of a submaximal concentration of IL-6, but increased responses to supramaximal IL-6 concentrations in a concentration-related manner. Dexamethasone increased the expression of the membrane IL-6R and endogenous sIL6R release, and increased responses to supramaximal but not submaximal IL-6 concentrations. The amount of endogenous sIL-6R released is relatively small and is unlikely to influence the effects of the exogenous sIL-6R. The observed concentration-related decrease in sIL-6R production in the presence of IL-6 may indicate internalization of ligand/receptor complexes. This would significantly decrease the amount of IL-6R (soluble or membrane) available for signalling and limit continued functional response later in the cultures. These data indicate that the major factor influencing responses to exogenous sIL-6R is an excess of IL-6 which is necessary to form complexes with the sIL-6R, which can then interact with gp130 to increase signalling.

MeSH terms

  • Carcinoma, Hepatocellular
  • Cell Membrane / immunology
  • Dexamethasone / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Humans
  • Interleukin-6 / genetics*
  • Interleukin-6 / pharmacology*
  • Liver Neoplasms
  • Receptors, Interleukin-6 / genetics
  • Receptors, Interleukin-6 / physiology*
  • Signal Transduction
  • Tumor Cells, Cultured

Substances

  • Interleukin-6
  • Receptors, Interleukin-6
  • Dexamethasone